These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 17889451)

  • 41. The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not.
    Sullivan LG
    Med J Aust; 1999 Aug; 171(3):165-6. PubMed ID: 10474613
    [No Abstract]   [Full Text] [Related]  

  • 42. Receptive syringe sharing and infection risk: to clean or not to clean.
    Gyarmathy VA
    J Infect Dis; 2010 Aug; 202(3):499; author reply 500-1. PubMed ID: 20597631
    [No Abstract]   [Full Text] [Related]  

  • 43. HIV-associated behaviors among injecting-drug users--23 Cities, United States, May 2005-February 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Apr; 58(13):329-32. PubMed ID: 19357632
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HIV prevention for injecting drug users: the first 25 years and counting.
    Des Jarlais DC; Semaan S
    Psychosom Med; 2008 Jun; 70(5):606-11. PubMed ID: 18519886
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India.
    Mahanta J; Medhi GK; Paranjape RS; Roy N; Kohli A; Akoijam BS; Dzuvichu B; Das HK; Goswami P; Thongamba G;
    AIDS; 2008 Dec; 22 Suppl 5():S59-68. PubMed ID: 19098480
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictors and correlates of reduced frequency or cessation of injection drug use during a randomized HIV prevention intervention trial.
    Mackesy-Amiti ME; Ouellet LJ; Golub ET; Hudson S; Hagan H; Garfein RS
    Addiction; 2011 Mar; 106(3):601-8. PubMed ID: 21182555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High prevalence of unprotected sex among Finnish HIV-positive and HIV-negative injecting drug users.
    Kivelä PS; Krol A; Partanen AL; Ristola MA
    Scand J Public Health; 2009 Jun; 37(4):357-63. PubMed ID: 19372233
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HIV revisited: preventing the spread of blood-borne viruses among injecting drug users.
    Wodak A; Crofts N
    Aust J Public Health; 1994 Sep; 18(3):239-41. PubMed ID: 7841248
    [No Abstract]   [Full Text] [Related]  

  • 49. Safer injection facilities (SIFs) for injection drug users (IDUs) in Canada. A review and call for an evidence-focused pilot trial.
    Fischer B; Rehm J; Kim G; Robins A
    Can J Public Health; 2002; 93(5):336-8. PubMed ID: 12353452
    [No Abstract]   [Full Text] [Related]  

  • 50. Condom use among injection drug users accessing a supervised injecting facility.
    Marshall BD; Wood E; Zhang R; Tyndall MW; Montaner JS; Kerr T
    Sex Transm Infect; 2009 Apr; 85(2):121-6. PubMed ID: 18812391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [AIDS and drug addiction in North America. Drug addiction epidemiology].
    Hankins C
    Sante; 1996; 6(2):76-8. PubMed ID: 8705133
    [No Abstract]   [Full Text] [Related]  

  • 52. Injecting drug use in India and the need for policy and program change.
    Panda S; Kumar MS
    Int J Drug Policy; 2016 Nov; 37():115-116. PubMed ID: 27771524
    [No Abstract]   [Full Text] [Related]  

  • 53. Impact of a harm-reduction programme on soft tissue infections among injecting drug users of Kolkata, India.
    Bhattacharya MK; Naik TN; Palit A; Bhattacharya SK
    J Health Popul Nutr; 2006 Mar; 24(1):121-2. PubMed ID: 16796159
    [No Abstract]   [Full Text] [Related]  

  • 54. Changes in the prevalence of HIV-related behaviors and perceptions among 1832 injecting drug users in Sichuan, China.
    Lau JT; Zhang L; Zhang Y; Wang N; Lau M; Tsui HY; Zhang J; Cheng F
    Sex Transm Dis; 2008 Apr; 35(4):325-35. PubMed ID: 18277942
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thinking ethically about needle and syringe programs.
    Kleinig J
    Subst Use Misuse; 2006; 41(6-7):815-25. PubMed ID: 16809168
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Co-occurrence of treatment nonadherence and continued HIV transmission risk behaviors: implications for positive prevention interventions.
    Kalichman SC
    Psychosom Med; 2008 Jun; 70(5):593-7. PubMed ID: 18519882
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HIV transmission among drug users in Larkana, Pakistan.
    ur Rehman N; Emmanuel F; Akhtar S
    Trop Doct; 2007 Jan; 37(1):58-9. PubMed ID: 17326898
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interest in HIV vaccines among Italian injection drug users. The Network Interregionale SERT.
    Serpelloni G; Vlahov D; Mazzi M; Rezza G
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):206-7. PubMed ID: 7552488
    [No Abstract]   [Full Text] [Related]  

  • 59. Young adult injection drug users in the United States continue to practice HIV risk behaviors.
    Rondinelli AJ; Ouellet LJ; Strathdee SA; Latka MH; Hudson SM; Hagan H; Garfein RS
    Drug Alcohol Depend; 2009 Sep; 104(1-2):167-74. PubMed ID: 19559543
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004.
    Holtzman D; Barry V; Ouellet LJ; Des Jarlais DC; Vlahov D; Golub ET; Hudson SM; Garfein RS
    Prev Med; 2009 Aug; 49(1):68-73. PubMed ID: 19410600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.